Verily launched Project Baseline in partnership with Durham, N.C.-based Duke University School of Medicine and Stanford (Calif.) Medicine in early 2017. The initiative aims to recruit participants for clinical research in order to establish a more accurate and representative map of population health, ultimately resulting in a searchable collection of clinical, behavioral, genetic, environmental, imaging and molecular data.
Within the new partnership, participants who have submitted their genetic information to Project Baseline will have access to Color’s physician-ordered, clinical-grade genomic services, board certified genetic counselors and clinical pharmacists, which, together, will provide a better understanding of participants’ genetic risks and predispositions.
The aim of the partnership is twofold, according to a blog post from Alicia Zhou, PhD, Color’s vice president of research and scientific affairs: to demonstrate researchers’ ethical responsibility to return results and insights to study participants, and to prove that offering actionable results can improve clinical research recruitment and engagement.
More articles on health IT:
Bayer offers grant funding, mentorship to 11 new digital health startup partners
UCSF Health Hub announces Digital Health Award winners: Livongo, 23andMe & more
NewYork-Presbyterian’s recipe for innovation: 80% people, 15% process, 5% technology
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.